TriSalus Life Sciences Prices $40M Public Offering at a Significant Discount

summarizeSummary

TriSalus Life Sciences priced a public offering of 9.76 million shares at $4.10 each, raising $40 million, which is a significant discount to the current market price and will result in substantial dilution.

check_boxKey Events

• Public Offering Priced

  TriSalus Life Sciences is offering 9,756,100 shares of common stock at a public offering price of $4.10 per share, aiming to raise approximately $40 million in gross proceeds.

• Significant Discount to Market

  The offering price of $4.10 per share is a substantial discount compared to the last reported sale price of $4.64 on February 18, 2026, and today's market price of $5.46.

• Potential Dilution

  The offering will increase the number of outstanding shares from 50,055,490 to 59,811,590 (or 61,275,005 if the over-allotment option is fully exercised), representing a potential dilution of approximately 19.5% (or 22.4% with over-allotment) based on shares outstanding as of January 31, 2026.

• Use of Proceeds

  Net proceeds, estimated at $37.0 million (or $42.64 million with over-allotment), are intended for general corporate purposes, including capital expenditures, working capital, and general and administrative expenses.

auto_awesomeAnalysis

This 424B5 prospectus supplement details the pricing and terms of a public offering, following the initial announcement of the offering. The offering of 9,756,100 shares at $4.10 per share, totaling $40 million, represents a substantial capital raise for TriSalus Life Sciences. However, the offering price of $4.10 is a notable discount compared to the last reported sale price of $4.64 on February 18, 2026, and a deeper discount to today's market price of $5.46. This pricing indicates a need for capital and could lead to significant dilution for existing shareholders. The company intends to use the net proceeds for general corporate purposes, including capital expenditures, working capital, and general and administrative expenses, which is a standard but non-specific use of funds.